Medical Oncology Workload in Europe: One Continent, Several Worlds.


Journal

Clinical oncology (Royal College of Radiologists (Great Britain))
ISSN: 1433-2981
Titre abrégé: Clin Oncol (R Coll Radiol)
Pays: England
ID NLM: 9002902

Informations de publication

Date de publication:
01 2020
Historique:
received: 22 01 2019
revised: 16 04 2019
accepted: 23 05 2019
pubmed: 22 7 2019
medline: 4 9 2020
entrez: 21 7 2019
Statut: ppublish

Résumé

The workload pressure on medical oncologists will increase in the near future. There are no comprehensive data available about the current workload of medical oncologists in Europe. Here we report the European results of a global survey of the workload of medical oncologists. An online survey was distributed through a snowball method via national oncology societies to chemotherapy-prescribing physicians in 21 European countries. We compared the workload of medical oncologists in Eastern European countries (EECs) and Western European countries (WECs). The primary measure of workload was the annual number of new cancer patient consults seen per oncologist. In total, 495 oncologists from 16 European countries completed our survey: 100 from seven EECs and 395 from nine WECs. The median number of annual consults per medical oncologist was 225 in EECs compared with 175 in WECs (P < 0.001). The proportion of medical oncologists seeing more than 300 consults/year was 35% (35/100) in EECs compared with 18% (68/395) in WECs. The median number of patients seen in a full day clinic was 25 in EECs and 15 in WECs (P < 0.001). Eastern European medical oncologists reported spending a median of 25 min per new consultation compared with 45 min in WECs (P < 0.001). The top two reported barriers in both EECs and WECs to patient care were high clinical volumes and insufficient time for reading. The clinical workload of medical oncologists in EECs was substantially higher than in WECs. European health policymakers and educators need to address existing disparities in the workload of medical oncologist, undertake plans for future workforce supply and consider alternative models of care.

Identifiants

pubmed: 31324474
pii: S0936-6555(19)30278-X
doi: 10.1016/j.clon.2019.06.017
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e19-e26

Informations de copyright

Copyright © 2019 The Royal College of Radiologists. All rights reserved.

Auteurs

B Seruga (B)

Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. Electronic address: bostser@yahoo.com.

R Sullivan (R)

Institute of Cancer Policy, King's College London, London, UK; King's Health Partners Comprehensive Cancer Centre, London, UK.

A Fundytus (A)

Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada.

W M Hopman (WM)

Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.

A Ocana (A)

Translational Research Unit, Albacete University Hospital, Albacete, Spain; CIBERONC, Albacete, Spain.

J Joffe (J)

Department of Medical Oncology, Calderdale and Huddersfield NHS Foundation Trust, Huddersfield, UK.

G Bodoky (G)

Department of Oncology, St László Teaching Hospital, Budapest, Hungary.

C Le Tourneau (C)

Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France.

V Vanderpuye (V)

Korle Bu Teaching Hospital, Accra, Ghana.

G Lopes (G)

University of Miami and Sylvester Comprehensive Cancer Center, Miami, Florida, USA.

N Hammad (N)

Department of Oncology, Queen's University, Kingston, Ontario, Canada.

M Sengar (M)

Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.

M D Brundage (MD)

Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada; Department of Oncology, Queen's University, Kingston, Ontario, Canada.

C M Booth (CM)

Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada; Department of Oncology, Queen's University, Kingston, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH